Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves
Disease Markers · 2024
DOI: 10.1155/2024/4782618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, 2024. Verfasst von Xiaofeng Dou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Lung cancer ranks first among malignant tumors worldwide and is a leading cause of cancer-related mortality in both men and women. Combining tumor marker testing is a strategy to screen individuals at high risk of pulmonary cancer and minimize pulmonary cancer mortality. Therefore, tumor marker screening is crucial. In this study, we analyzed combinations of tumor markers for lung cancer screening using receiver operating characteristic (ROC) curve analysis.
Methods
A retrospective descriptive study was conducted on patients diagnosed with lung cancer, as well as healthy and benign lung diseases, using data from the China Huludao Central Hospital database between January 2016 and July 2022. The t-test and ROC curve were utilized to assess the effectiveness of individual tumor marker and the combination of multiple tumor markers. Tumor markers are molecular products metabolized and secreted by tumor tissues, characterized by cells or body fluids. They serve as indicators of tumor stage and grading, monitor treatment response, and predict recurrence.
Results
In this study, 267 healthy participants, 385 patients with benign lesions, and 296 patients with lung cancer underwent tumor marker screening. The sensitivity of five tumor markers—CEA, CYFRA21-1, NSE, pro-GRP, and CA125—was found to be
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
ORCID-Profile: Xiaofeng Dou, Jiachen Lu, Yingying Yu, Yaohui Yi, Ling Zhou
Zitieren
APA
Dou, X., Lu, J., Yu, Y., Yi, Y., & Zhou, L. (2024). Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves. Disease Markers. https://doi.org/10.1155/2024/4782618
Vancouver
Dou X, Lu J, Yu Y, Yi Y, Zhou L. Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves. Disease Markers. 2024. doi:10.1155/2024/4782618
BibTeX
@article{Dou2024,
author = {Dou, Xiaofeng and Lu, Jiachen and Yu, Yingying and Yi, Yaohui and Zhou, Ling},
title = {Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves},
journal = {Disease Markers},
year = {2024},
doi = {10.1155/2024/4782618}
}
EUVIMED